Q2 2025
Released Aug 13, 2025, before the open
10-Q filed Aug 13, 2025, 44 days after period end · 0000868278-25-000011
Q2 2025 · 10-Q
Revenue$1.25M$1.25M −17.1% vs Q2 2024−12.9% vs Q1 2025
Net Income-$4.47M-$4.47M N/M vs Q2 2024N/M vs Q1 2025
EPS Diluted-$1.08-$1.08 N/M vs Q2 2024N/M vs Q1 2025
Gross Profit$734,000N/M
Operating Income-$3,894,000N/M
Operating Cash Flowderived-$247,000N/M
Free Cash Flowderived-$247,000N/M
Margins · derived
Gross margin58.9%+69.2 pt vs Q2 2024
Operating margin-312.3%+168.3 pt vs Q2 2024
Net margin-358.6%+50.5 pt vs Q2 2024
What the release said
The release
Same quarter
| Metric | Q2 2025 | Q2 2024 | Q2 2023 | Q2 2022 |
|---|---|---|---|---|
| Revenue | $1.25M | $1.50M | $13.22M | $29.09M |
| Net Income | -$4.47M | -$6.15M | -$3.44M | $7.45M |
| EPS Diluted | -$1.08 | -$0.33 | -$0.20 | $0.40 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR